Bitget announced that its assets under management (AUM) surpassed $100 million one month after the launch of its stock token (rToken) product. As of July 6, the number of users participating in related asset trading exceeded 100,000, with a cumulative trading volume of $671.37 million. In terms of asset distribution, rSPCX currently has the highest TVL (TVL) among rTokens, accounting for 23.51%; rCSCO and rNVDA follow with 17.75% and 13.38% respectively. The overall ranking shows that early demand for rTokens was mainly driven by high-profile private market assets and technology-related targets, with AI infrastructure assets becoming an important demand cluster, covering areas such as networking, chips, storage, and semiconductors. It is understood that rTokens, identified by the letter r + stock code (such as rNVDA for Nvidia), are issued by Reality, Bitget's licensed RWA protocol, and are directly connected to global liquidity pools such as Nasdaq and the NYSE through cooperation with compliant brokerage firm Alpaca. Its features include: 1:1 reserves of underlying assets held in custody by a licensed custodian; 1:1 distribution of stock dividends in token form; support for synchronized mapping of corporate actions such as stock splits and consolidations; and the ability for holdings to serve as joint margin for unified accounts and USDT-based contracts, allowing users to flexibly manage funds while holding global stock assets.

According to an article by on-chain investigator ZachXBT, published by Odaily Planet Daily, the LAB token has plummeted from $14 to less than $2 in the past 24 hours, a drop of approximately 85%, resulting in a significant reduction in its fully diluted valuation (FDV) from approximately $14 billion. ZachXBT expressed disappointment that Binance, Bitget, and Gate failed to take proactive measures to prevent price manipulation, stating that if centralized exchanges truly valued user interests, they should at least return the profits of accounts suspected of market manipulation to users. He further pointed out that LAB investors were originally scheduled to begin unlocking their tokens later this month, but the vesting arrangements have been repeatedly altered. Insiders have long controlled almost the entire circulating supply and have been using market makers to conduct extreme price manipulation on centralized exchanges; therefore, he "does not recommend trading LAB under any circumstances."